We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

New Monoclonal Antibodies to the Dengue Virus NS1

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Dengue Virus is endemic in tropical countries world wide. It causes an insect-borne (mosquitoes) infection that manifests as Dengue Fever.

However the infection can progress to more serious conditions including hemorrhagic fever. There are 4 serotypes of the virus and all are capable of causing disease.

A non-structural glycoprotein (NS1) is produced during acute infection and can be found at high levels in patient serum.

ViroStat has released several new monoclonal antibodies to the NS1 of Dengue virus.

These antibodies recognize the NS1 protein of all 4 Dengue serotypes and are powerful tools for researchers and developers of rapid detection methods.